;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Cynapsus amends private placement of units

    Cynapsus Therapeutics Inc. (TSX:CTH), Toronto, Ontario Business: Drug delivery, Neurology Date announced: 4/8/14 Type: Private placement of units To be raised: Up to C$25 million ($22.8 million) Units: 38.5 million …

    Published on 4/14/2014
  • Vital Therapies amends IPO

    Vital Therapies Inc., San Diego, Calif. Business: Hepatic Date announced: 4/7/14 Type: IPO To be raised: Up to $63 million Shares: 4.5 million Price: $13-$15 Underwriters: BofA Merrill Lynch; Credit Suisse; William …

    Published on 4/14/2014
  • Adamas Pharmaceuticals completes IPO

    Adamas Pharmaceuticals Inc. (NASDAQ:ADMS), Emeryville, Calif. Business: Neurology, Infectious Date completed: 4/9/14 Type: IPO Raised: $48 million Shares: 3 million Price: $16 Shares after offering: 16.4 million …

    Published on 4/14/2014
  • Adaptive Biotechnologies completes venture financing

    Adaptive Biotechnologies Corp., Seattle, Wash. Business: Bioinformatics Date completed: 4/7/14 Type: Venture financing Raised: $20 million Investors: Viking Global Investors; individual investors Note: Adaptive said it …

    Published on 4/14/2014
  • Adaptive Biotechnologies completes venture financing

    Adaptive Biotechnologies Corp., Seattle, Wash. Business: Bioinformatics Date completed: 4/7/14 Type: Venture financing Raised: $100 million Investor: Viking Global Investors Note: The financing is a series D round.

    Published on 4/14/2014
  • AdvanDx completes venture financing

    AdvanDx Inc., Woburn, Mass. Business: Diagnostic Date completed: 4/8/14 Type: Venture financing Raised: $9 million Investors: Merck Global Health Innovation Fund; SLS Invest; LD Pension Fund Note: The company raised $9 …

    Published on 4/14/2014
  • Alios completes venture financing

    Alios BioPharma Inc., South San Francisco, Calif. Business: Infectious Date completed: 4/7/14 Type: Venture financing Raised: $41 million Investors: Novo Ventures; SR One; Roche Venture Fund; Novartis Venture Funds; and…

    Published on 4/14/2014
  • Assembly completes venture financing

    Assembly Pharmaceuticals Inc., San Francisco, Calif. Business: Infectious Date completed: 4/10/14 Type: Venture financing Raised: Not disclosed. Investors: Luson Bioventures; BioCrossroads; Johnson & Johnson Development…

    Published on 4/14/2014
  • Cerulean completes IPO

    Cerulean Pharma Inc. (NASDAQ: CERU), Cambridge, Mass. Business: Drug delivery, Cancer Date completed: 4/10/14 Type: IPO Raised: $59.5 million Shares: 8.5 million Price: $7 Shares after offering: 19 million Underwriters:…

    Published on 4/14/2014
  • Cyclacel completes follow-on

    Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC), Berkeley Heights, N.J. Business: Cancer Date completed: 4/4/14 Type: Follow-on Raised: $10 million Shares: 2.9 million Price: $3.50 Shares after offering: 22.7 million …

    Published on 4/14/2014
  • Genomind completes venture financing

    Genomind LLC, Chalfont, Pa. Business: Neurology Date completed: 4/9/14 Type: Venture financing Raised: $5 million Investor: Claritas Capital

    Published on 4/14/2014
  • kaleo completes venture financing

    kaleo Inc., Richmond, Va. Business: Drug delivery Date completed: 4/7/14 Type: Venture financing Raised: $150 million Investor: PDL BioPharma Inc. Note: The notes bear 13% interest and mature in March 2029. The notes …

    Published on 4/14/2014
  • Kindred Biosciences completes IPO

    Kindred Biosciences Inc. (NASDAQ:KIN), Burlingame, Calif. Business: Veterinary Date completed: 4/3/14 Type: IPO Raised: $62.1 million Shares: 3.5 million Price: $18 Shares after offering: 19.7 million Underwriters: …

    Published on 4/14/2014
  • Neptune Technologies completes private placement

    Neptune Technologies & Bioressources Inc. (NASDAQ: NEPT; TSX:NTB), Laval, Quebec Business: Nutraceuticals, Cardiovascular, Neurology Date completed: 4/4/14 Type: Private placement Raised: C$2.5 million ($2.3 million) …

    Published on 4/14/2014
  • Newron completes private placement

    Newron Pharmaceuticals S.p.A. (SIX:NWRN), Bresso, Italy Business: Neurology Date completed: 4/7/14 Type: Private placement Raised: CHF18.6 million ($20.9 million) Shares: 1.2 million Price: CHF15.75 Shares after …

    Published on 4/14/2014
  • NuCana BioMed completes venture financing

    NuCana BioMed Ltd., Edinburgh, U.K. Business: Cancer Date completed: 4/10/14 Type: Venture financing Raised: $57 million Investors: Sofinnova Ventures; Sofinnova Partners; Morningside Venture Investments; Alida Capital …

    Published on 4/14/2014
  • Ohr completes direct public offering

    Ohr Pharmaceutical Inc. (NASDAQ:OHRP), Salt Lake City, Utah Business: Ophthalmic, Endocrine/Metabolic, Cancer Date completed: 4/8/14 Type: Direct public offering Raised: $18 million Shares: 1.8 million Price: $10 Shares…

    Published on 4/14/2014
  • Pacira completes follow-on

    Pacira Pharmaceuticals Inc. (NASDAQ:PCRX), Parsippany, N.J. Business: Drug delivery, Neurology, Cancer Date completed: 4/8/14 Type: Follow-on Raised: $102.4 million Shares: 1.6 million Price: $64 Shares after offering: …

    Published on 4/14/2014
  • Personal Genome Diagnostics completes venture financing

    Personal Genome Diagnostics Inc., Baltimore, Md. Business: Diagnostic Date completed: 4/2/14 Type: Venture financing Raised: $2.8 million Investors: Private investors

    Published on 4/14/2014
  • ProteoMediX completes venture financing

    ProteoMediX AG, Zurich, Switzerland Business: Cancer, Diagnostic Date completed: 4/9/14 Type: Venture financing Raised: CHF3.2 million ($3.6 million) Investors: Altos Venture; Zuercher Kantonalbank; existing investors

    Published on 4/14/2014
  • Quantum Genomics completes private placement

    Quantum Genomics Corp. (Euronext:QGCNR), Massy, France Business: Cardiovascular Date completed: 4/9/14 Type: Private placement Raised: 3.4 million ($4.7 million) Shares: 637,334 Price: 5.35 Shares after offering: 4.7 …

    Published on 4/14/2014
  • RefleXion Medical completes venture financing

    RefleXion Medical Inc., Burlingame, Calif. Business: Diagnostic Date completed: 4/3/14 Type: Venture financing Raised: $11.6 million Investors: Sofinnova Partners; Pfizer Venture Investments; Venrock

    Published on 4/14/2014
  • Regado Biosciences completes follow-on

    Regado Biosciences Inc. (NASDAQ:RGDO), Basking Ridge, N.J. Business: Cardiovascular Date completed: 4/11/14 Type: Follow-on Raised: $60 million Shares: 10 million Price: $6 Shares after offering: 33.3 million …

    Published on 4/14/2014
  • Relypsa completes follow-on

    Relypsa Inc. (NASDAQ:RLYP), Redwood City, Calif. Business: Endocrine/Metabolic Date completed: 4/10/14 Type: Follow-on Raised: $88 million Shares: 3.6 million Price: $24.50 Shares after offering: 33.3 million …

    Published on 4/14/2014
  • Spero Therapeutics completes venture financing

    Spero Therapeutics LLC, Cambridge, Mass. Business: Infectious Date completed: 4/9/14 Type: Venture financing Raised: $3 million Investors: Atlas Ventures; SR One; Partners Innovation Fund

    Published on 4/14/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993